Holy Cross Hospital Selects Aspyra's Laboratory and Pathology Information Systems to Streamline Workflow

Business Wire, Nov 7, 2006

CALABASAS, Calif. -- Aspyra, Inc. (AMEX:APY) announced today that the Company has contracted with Holy Cross Hospital, a 241-bed independent community-based healthcare facility in Chicago, to provide Aspyra's CyberLAB([R]) Laboratory Information System (LIS) and CyberPATH([R]) Anatomic Pathology system solutions.

Gary Gremo, LIS Coordinator for Holy Cross Hospital, stated, "Our selection process was thorough and included a number of vendors and the participation of key core organization staff. Aspyra's products were superior with regard to ease of navigation and functionality. The Company's reputation of positive customer service and its corporate references regarding system implementation and upkeep were instrumental in the hospital's decision-making process."

"The hospital selected the Aspyra CyberLAB([R]) system based on its functional features for all aspects of the laboratory," stated Carolyn Blake, Director of Laboratory and Respiratory Care for Holy Cross Hospital. She continued, "The laboratory staff involved in the selection process is excited with the prospect of online faxing of results, autoverification, and streamlined workflow monitoring. Clearly, the Aspyra system offered the broadest functionality and combined with affordability."

Aspyra's CyberLAB([R]) LIS system is a scalable, feature-rich, and proven LIS solution for the hospital, clinic, and reference laboratory settings. CyberLAB([R]) features decision support tools with auto-verification, automated clinical reporting and multisite management.

The Company's CyberPATH([R]) Anatomic Pathology system is designed by pathologists and other healthcare professionals to optimize efficient and cost-effective work-flow applications for anatomic pathology and cytology departments. CyberPATH([R]) tools ensure timely and accurate data acquisition and information access for physicians, pathologists, technologists, histologists and clerical staff.

Initial training sessions for HCH staff will begin mid-November at the Company's corporate offices in Calabasas, Calif. Tami Tressel, Aspyra's Director of Implementations, stated, "Combining our detailed workflow analysis of the facility, along with our experience in the community-based hospital environment, we will incorporate our LIS in a manner that best fits the facility to allow for optimal efficiency."

About Holy Cross Hospital

Founded by the Sisters of St. Casimir in 1927, Holy Cross Hospital is a not-for-profit neighborhood health system serving residents of Chicago's southwest neighborhoods and suburbs. Over 250 doctors and 1000 employees provide outstanding health care at Holy Cross Hospital facilities, with a 241 bed hospital providing a comprehensive range of services, including emergency care, inpatient, outpatient, and surgical services and primary care at three neighborhood affiliate locations.

About Aspyra, Inc.

Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers, orthopedic environments and pharmacies. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com.

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.